Varicella zoster (VZV)-infection of the central nervous system (CNS) – PCR levels, clinical syndromes and neurological complications
block.GIF (810 bytes)
Library

 
Download Acrobat Reader

To view some of the files in this section, you will require a version of Adobe Acrobat. This is free to download and is available on the Adobe Acrobat website.

Download PowerPoint Viewer

To view the PowerPoint presentations you will require Microsoft PowerPoint. You can download the latest PowerPoint viewer free from the Microsoft website.

You are welcome to download, view and use many of the slides contained in these presentations, however the original presenter and IHMF® must be suitably acknowledged for any use, for example in oral presentations or written material. Please also be aware that some slides contain graphs, illustrations or other content that may not be the copyright of the presenter or the IHMF® and permission ot use such material will need to be obtained from the copyright owner prior to use. Some of the slide presentations from the 13th IHMF® Annual Meeting are subject to 'restricted use' and the presentations to which this applies are labelled with the notice 'Restricted Use - please contact the presenter prior to any use of the content of this presentation'. These 'restricted use' presentations may only be viewed online or downloaded to view, and the original presenter must be contacted prior to any use.

If you are in any doubt about your use of this material, please contact the IHMF Secretariat.

Varicella zoster (VZV)-infection of the central nervous system (CNS) – PCR levels, clinical syndromes and neurological complications
Anna Persson, Tomas Bergström, Lars Hagberg, Marie Studahl
Departments of Infectious diseases and Virology, Sahlgrenska University Hospital, Göteborg, Sweden

Background:. Quantitative polymerase chain reaction (PCR) has improved the diagnosis of VZV-infection of the CNS. The correlation between the viral load and symptoms, prognosis and effect of treatment is not yet known. The main aim of this study was to describe the clinical manifestations of patients with VZV DNA positivity in the CSF.

Patients and methods: Patients in the Västra Götaland region in Sweden with VZV-infection of the CNS during 1995-2006 were identified. The diagnoses, laboratory tests (including virus amount), x-ray examinations, antiviral treatment and neurological sequelae have been studied.

Results: 97 of the 100 charts have been obtained. 28% had the diagnosis encephalitis or meningoencephalitis and 34% meningitis, 20% Ramsay Hunt’s syndrome and the remaining had infarction or bleeding, encephalopathy or other neurological complications. In 66 patients PCR levels were measured, there is a significant difference between the Ramsay-Hunt group and the encephalitis group and between the Ramsay-Hunt group and the meningitis group. In 37% there were no skin manifestations observed. 62% had CT scan or MRI of the brain performed and of these, 40% had pathological findings. Of the 45% who were followed-up, approximately ¾ had neurological complications one month after discharge.

Conclusions: A considerable number of the patients with VZV-infection in CNS had serious neurological symptoms and sequelae. Less than half of the patients had skin manifestations before onset of neurological complications, which might delay diagnosis and start of antiviral treatment. Quantitative PCR in cerebrospinal fluid (CSF) is a sensitive method to detect VZV-infection of the CNS.

 


 

- - - -
The IHMF® is a registered trademark of PAREXEL MMS
© 1998-2007 Cambridge Medical Publications. All rights reserved.
Last Updated : 04/12/2007 13:43:00